Therapeutic plasma exchange (TPE) was used in 146 patients with hemato
logic disorders: hyperviscosity syndrome, 74; cryoglobulinemia, 53; po
rphyria, 9; immune complex disease, 3; cold agglutinin disease, 1; hem
olytic uremic syndrome, 1; autoimmune hemolytic anemia, 1; autoimmune
thrombocytopenia, 1; autoimmune neutropenia, 1; Clq deficiency, 1; and
secondary immunodeficiency, 1. It was shown that TPE applied in patie
nts with hyperviscosity syndrome resulted in rapid reduction of parapr
otein concentrations, and normalization or significant decrease of ser
um viscosity associated with marked clinical improvement (regression o
f neurologic, renal, hematologic, visual and other disturbances). Appl
ication of TPE in patients with cryoglobulinemia resulted in plasma cr
yoglobulin reduction and clear clinical effects (blood flow improvemen
t, skin ulcer healing, reversal of impaired renal function and disappe
arance of purpura and other abnormalities). Very good results were obt
ained in patients with porphyria (decreased sensitivity to sunlight) a
nd also in patients with Clq deficiency. Satisfactory clinical improve
ment and better laboratory findings were also seen in patients with im
mune complex disease, autoimmune hemolytic anemia, autoimmune thromboc
ytopenia and hemolytic uremic syndrome.